Suchergebnisse - "Risk Assessment"

PubPharm (22)

1

Difference Between Cardiopulmonary Bypass Time and Aortic Cross-Clamping Time as a Predictor of Complications After Coronary Artery Bypass Grafting

enthalten in: Brazilian journal of cardiovascular surgery | 2024

von Jucá, F. | Freitas, F. | Goncharov, M. | +6

2

Framingham risk score is associated with hearing outcomes in patients with idiopathic sudden sensorineural hearing loss

enthalten in: The Journal of laryngology and otology | 2020

von Chang, Y. | Park, S. | Lee, M. | +2

3

Prosthesis-Patient Mismatch after Surgical Aortic Valve Replacement : Neither Uncommon nor Harmless

enthalten in: Brazilian journal of cardiovascular surgery | 2019

von Rayol, S. | Sá, M. | Cavalcanti, L. | +6

4

Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2017

von Lüders, F. | Kaier, K. | Kaleschke, G. | +7

5

Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2017

von Chen, Y. | Chen, H. | Hsu, C. | +4

6

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?

enthalten in: Journal of Korean medical science | 2015

von Lee, H. | Jeon, H. | Jeong, B. | +4

7

Long-term follow-up of kidney transplant recipients with polycystic kidney disease

enthalten in: Experimental and clinical transplantation | October 2015

von Mehrabi, A. | Golriz, M. | Maier, J. | +14

8

A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery : the APAP trial (ISRCTN45810007)

enthalten in: Langenbeck's archives of surgery | 2012

von Antolovič, D. | Rakow, A. | Contin, P. | +5

9

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland : a consensus report

enthalten in: Lupus | 2012

von Aringer, M. | Lorenz, H.

10

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia

enthalten in: Journal of clinical oncology | March 21, 2011

von Hehlmann, R. | Lauseker, M. | Jung-Munkwitz, S. | +17